$ACHV 4 SEC Filings

Filed On	Filing
06 Oct 2026	Form 4: Halladay Benjamin, Chief Financial Officer Granted 200,000 Stock Option (right to buy) · Granted 200,000 Restricted Stock Unit (RSU)
21 Aug 2026	Form 4: Stewart Richard Alistair, Director Sold 20,626 shares ($175K)
29 Jul 2026	Form 4: Sellig Thomas, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Martin Christopher Nathan, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Royston Aaron, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Waldman Reid Alexander, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Stewart Richard Alistair, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Farrow Jeffrey S, Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
29 Jul 2026	Form 4: Phelan Nancy R., Director Granted 25,000 Stock Option (right to buy) · Granted 16,700 Restricted Stock Unit (RSU)
02 Jun 2026	Form 4: Waldman Reid Alexander, Director Granted 47,250 Stock Option (right to buy)
02 Jun 2026	Form 4: Farrow Jeffrey S, Director Granted 47,250 Stock Option (right to buy)
13 May 2026	Form 4: Martin Christopher Nathan, Director Granted 47,250 Stock Option (right to buy)
21 Apr 2026	Form 4: Goldberg Andrew D., Director Granted 1,800,965 Restricted Stock Unit (RSU) · Granted 3,601,929 Stock Option (right to buy) · Granted 11,706,270 Performance Restricted Stock Unit (PRSU)
30 Jan 2026	Form 4: Rubinstein Mark Lawrence, Chief Medical Officer Granted 180,000 Stock Option (right to buy)
30 Jan 2026	Form 4: Oki Mark K, Chief Financial Officer Granted 180,000 Stock Option (right to buy)
30 Jan 2026	Form 4: Xinos Jaime, Chief Commercial Officer Granted 180,000 Stock Option (right to buy)
30 Jan 2026	Form 4: Donnelly Craig, Chief Operations Officer Granted 180,000 Stock Option (right to buy)
30 Jan 2026	Form 4: Stewart Richard Alistair, Director Granted 645,000 Stock Option (right to buy)
30 Jan 2026	Form 4: Wan Jerry, Principal Accounting Officer Granted 70,300 Stock Option (right to buy)
08 Dec 2025	Form 4: Atkisson Erik, Chief Legal Officer Granted 250,000 Stock Option (right to buy)

Comments